Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC

Belgium - Celyad Oncology SA (Euronext: CYAD) ('Celyad Oncology' or the 'Company') today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market, that it received a notification of transparency dated November 17, 2023, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 50%, holding 22,858,654 shares i.e. 52.19% of Celyad Oncology's voting rights.

Contact:

Tel: [phone]

Fax: [phone]

Email: [e-mail]

(C) 2023 Electronic News Publishing, source ENP Newswire